Your Neurotransmitters Are Imbalanced. Your Genes Explain Why.

The COMT enzyme has one job: break down stress hormones (dopamine, norepinephrine, epinephrine) so they don’t accumulate in your brain and keep you in a state of perpetual alertness. When COMT works normally, stress hormones spike briefly in response to a real threat, then are rapidly cleared. Your nervous system returns to baseline. You feel calm again.

The Val158Met variant changes how efficiently COMT breaks down these chemicals. People carrying the Met variant (roughly 25% of people with European ancestry) have a slower COMT enzyme. Stress hormones clear more slowly, so they linger in your system, keeping your nervous system primed for threat even when the danger has passed. This creates persistent, low-grade anxiety that feels constant rather than situational.

You notice this as a kind of background hum of worry. You’re reactive to small stressors that wouldn’t bother other people. You feel more wired after caffeine and energy drinks. Your mind races at night. You struggle to shift out of fight-or-flight mode, even when you’re home and safe.

Once your brain releases serotonin to communicate a sense of calm and wellbeing, it needs to be recycled. The serotonin transporter, controlled by the SLC6A4 gene, pulls serotonin back into the nerve ending so it can be reused. This recycling system is how your brain maintains stable mood and anxiety tolerance.

The 5-HTTLPR short allele variant impairs this recycling process. Roughly 40% of the population carries at least one short allele. With the short variant, your brain recycles serotonin less efficiently, so you have less serotonin available between nerve cells. Standard SSRIs work by blocking reuptake, but if your transporter is already weak, blocking it further doesn’t help as much as it should.

You experience this as fragile emotional resilience. Stressors that others bounce back from hit you harder and take longer to recover from. Your mood feels dependent on external validation. You’re prone to rumination and have difficulty shifting your attention away from negative thoughts. Rejection sensitivity is pronounced.

After serotonin, dopamine, and norepinephrine are recycled back into nerve endings, they must eventually be broken down so your brain doesn’t accumulate excessive amounts. The MAOA enzyme handles this job. It’s a precise balancing act: break down enough to prevent excess, but not so much that you’re constantly depleted.

The MAOA-L (low activity) variant reduces the enzyme’s efficiency. Roughly 30 to 40% of males carry this variant. With low MAOA activity, neurotransmitters accumulate and persist longer, creating fluctuating levels that your brain struggles to regulate. This is different from having too little neurotransmitter; instead, you have unstable levels that spike and crash.

You notice this as mood swings and emotional volatility. You might feel fine one moment and overwhelmingly angry or sad the next. Your stress response is heightened and unpredictable. You’re sensitive to stimulants and may experience anxiety or irritability with caffeine. Impulsivity is higher than you’d like, and emotional control takes constant effort.

Serotonin doesn’t exist in your brain until your body makes it. The rate-limiting step in brain serotonin synthesis is the TPH2 enzyme, which converts the amino acid tryptophan into 5-hydroxytryptophan, the precursor to serotonin. If TPH2 doesn’t work efficiently, your brain simply can’t make enough serotonin, no matter how much tryptophan you consume.

Variants in the TPH2 gene reduce enzyme activity. Roughly 20% of the population carries a TPH2 variant. With reduced TPH2 activity, your brain produces less serotonin from the start, creating a baseline deficit that no amount of dietary tryptophan can fully overcome. This is particularly relevant if SSRIs haven’t worked: if you’re not making enough serotonin in the first place, recycling what little you have won’t solve the problem.

You experience this as a fundamental vulnerability to depression. Your mood feels fragile and dependent on external support. You lack the biological buffer that allows other people to weather stress and loss without spiraling. Sleep is often poor. Your nervous system feels weak. You may struggle with seasonal mood changes, especially in winter when daylight is limited.

GABA is your brain’s primary calming neurotransmitter. It’s the chemical that allows your nervous system to downregulate, to slow your thoughts, to feel safe and relaxed. The GAD1 enzyme synthesizes GABA from the amino acid glutamate. Without sufficient GAD1 activity, your brain can’t produce enough GABA to balance the excitatory tone in your nervous system.

Variants in GAD1 reduce enzyme activity. Roughly 20 to 30% of the population carries a GAD1 variant. With lower GAD1 activity, your brain has reduced inhibitory tone, meaning your nervous system runs in a more excited state than is optimal, even at rest. This is why anxiety feels baseline for you: your nervous system lacks the chemical brake that allows others to feel calm without effort.

You experience this as persistent nervousness. Your mind doesn’t settle easily. You’re hypervigilant to threat, even in safe environments. Relaxation doesn’t come naturally. Sleep onset is difficult because your nervous system won’t downregulate. You may be sensitive to stimulating foods and substances. Alcohol initially calms you (because it boosts GABA), but dependence can develop quickly because you’re self-medicating a genuine deficit.

MTHFR is arguably the most critical gene in neurotransmitter production because it controls methylation, the chemical process that powers synthesis of dopamine, serotonin, norepinephrine, and GABA. MTHFR converts dietary folate into the active form (methylfolate) that your cells can actually use. Without this conversion, your methylation cycle stalls, and neurotransmitter synthesis tanks.

The C677T variant reduces MTHFR enzyme activity. Roughly 40% of people with European ancestry carry this variant. With the C677T variant, you may have adequate dietary folate but functionally low methylfolate, creating a cellular bottleneck that slows neurotransmitter production across the board. Standard folate supplements don’t bypass this problem; you need the already-methylated form to circumvent the broken enzyme.

You experience this as low mood baseline, poor stress resilience, and difficulty generating motivation or pleasure. Your emotions feel muted. Antidepressants often underperform because your brain isn’t making enough neurotransmitter raw material for the medications to work with. You may have other methylation-dependent symptoms: poor detoxification, sensitivity to toxins, inadequate DNA repair. Your mood worsens with stress because stress depletes your already-limited methylation capacity.